Genetesis IPO

genetesis.com/Healthcare / BioTech & Pharma

Genetesis is a biopharma company focusing on the treatment of heart diseases and chest pain using digital and electric imaging technology. Genetesis has developed its Cardioflux imaging device, in which a patient can pass through, and by using magnetocardiography, it can pick up natural magnetic signals produced in the heart for optimal treatment and diagnosis options. Genetesis partners with healthcare organizations to bring its devices to the patients that could benefit from this type of cardiac care.

Buy or sell Genetesis stock Learn more about Genetesis stock

What is Genetesis's ticker symbol?

Genetesis does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Genetesis's stock price?

The stock price for Genetesis will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Genetesis's major investors?

Mithril Capital Mangement

Ohio Innovation Fund

JobsOhio Growth Capital Fund

CincyTech

Cercano Management

Learn more about Genetesis

When was Genetesis founded?

Genetesis was founded in 2013.

Can you invest in Genetesis?

Genetesis is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Genetesis share pre-IPO?

If you own Genetesis pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Genetesis a publicly traded company?

Genetesis is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.